Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer
Clinical trial NCT05257512 · UNKNOWN
Trial details
- NCT number
- NCT05257512
- Sponsor
- Shouyao Holdings (Beijing) Co. LTD
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-26
- Primary completion
- 2024-04-26
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.